Pharmaceutical Products & Market Pfizer's financial key figures 2020 This Pfizer 2020 business report presents the course of business throughout the respective business year.

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6% ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

From tinted formulas to serum-like sunscreens, our guide will help you choose a sunscreen you'll actually wear.

Pfizer’s PFE top line has been declining in 2023 due to a steep drop in revenues from its COVID-19 products, the Comirnaty vaccine and Paxlovid oral pill, on lower demand due to the end of the ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...

Pfizer (PFE) stock slips as former executives Ian Read and Frank D'Amelio exit Starboard Value's activist campaign against ...

Activist investor Starboard Value's $1 billion stake in Pfizer may not address the company's underlying growth ...

Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years? Does this sound a bit ...

"Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing ...